Deutsche Bank
KZR

Deutsche Bank’s Kezar Life Sciences KZR Stock Holding History

Deutsche Bank’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-27,927
Closed -$215K – 3667
2024
Q3 		$215K Hold
27,927
– – ﹤0.01% 2892
2024
Q2 		$168K Hold
27,927
– – ﹤0.01% 2904
2024
Q1 		$251K Hold
27,927
– – ﹤0.01% 2710
2023
Q4 		$265K Buy
27,927
+23,323
+507% +$205K ﹤0.01% 2718
2023
Q3 		$54.8K Sell
4,604
-28,341
-86% -$502K ﹤0.01% 3388
2023
Q2 		$807K Buy
32,945
+687
+2% +$17.9K ﹤0.01% 2097
2023
Q1 		$1.01M Buy
32,258
+1,489
+5% +$86.2K ﹤0.01% 2099
2022
Q4 		$2.17M Buy
30,769
+638
+2% +$47.3K ﹤0.01% 1614
2022
Q3 		$2.59M Buy
30,131
+5
+0% +$486 ﹤0.01% 1485
2022
Q2 		$2.49M Buy
30,126
+265
+0.9% +$23.4K ﹤0.01% 1639
2022
Q1 		$4.96M Sell
29,861
-228
-0.8% -$32.7K ﹤0.01% 1426
2021
Q4 		$5.03M Sell
30,089
-49,065
-62% -$5.54M ﹤0.01% 1431
2021
Q3 		$6.84M Sell
79,154
-5
-0% -$331 ﹤0.01% 1342
2021
Q2 		$4.3M Buy
79,159
+77,122
+3,786% +$4.38M ﹤0.01% 1636
2021
Q1 		$121K Sell
2,037
-190
-9% -$11.1K ﹤0.01% 3877
2020
Q4 		$116K Buy
2,227
+658
+42% +$36.6K ﹤0.01% 3765
2020
Q3 		$76K Buy
1,569
+320
+26% +$15.3K ﹤0.01% 3669
2020
Q2 		$65K Sell
1,249
-1,068
-46% -$53.9K ﹤0.01% 3677
2020
Q1 		$101K Sell
2,317
-732
-24% -$29.8K ﹤0.01% 3243
2019
Q4 		$121K Buy
3,049
+610
+25% +$18.8K ﹤0.01% 3490
2019
Q3 		$78K Buy
2,439
+1,309
+116% +$63.2K ﹤0.01% 3693
2019
Q2 		$85K Sell
1,130
-481
-30% -$74.8K ﹤0.01% 4279
2019
Q1 		$285K Buy
1,611
+934
+138% +$184K ﹤0.01% 3790
2018
Q4 		$159K Sell
677
-489
-42% -$120K ﹤0.01% 3995
2018
Q3 		$249K Buy
+1,166
New +$204K ﹤0.01% 4131

Other funds holding KZR

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $122M AUM 67.29% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Deutsche Bank's KZR Position: Q4 2024 in Review

Deutsche Bank sold out of Kezar Life Sciences (KZR) in Q4 2024, closing a stake of 27,927 shares — an estimated $215K sold.

Deutsche Bank first reported a position in KZR in Q3 2018 and held it in 25 quarters. The position peaked at $6.84M in Q3 2021. 43 funds tracked by Wall St. Rank hold KZR as of Q4 2024.

  • Deutsche Bank reported no remaining Kezar Life Sciences position as of Q4 2024 after selling out during the quarter.
  • Deutsche Bank sold 27,927 Kezar Life Sciences shares in Q4 2024, an estimated $215K.
  • Deutsche Bank first reported a position in Kezar Life Sciences in Q3 2018 and held it in 25 quarters.
  • Deutsche Bank's Kezar Life Sciences position peaked at $6.84M in Q3 2021.
  • 43 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q4 2024.

Based on Deutsche Bank's 13F filing for Q4 2024, filed 14 Feb 2025.